Literature DB >> 15675473

Vertebroplasty and kyphoplasty in the treatment of malignant vertebral fractures.

S Masala1, P Lunardi, R Fiori, G Liccardo, F Massari, A Ursone, G Simonetti.   

Abstract

The purpose of this retrospective study was to assess the effectiveness and safety of Percutaneous Vertebroplasty and Kyphoplasty, in the treatment of pain deriving from neoplastic vertebral compression fractures (VCF). We treated 33 oncologic patients with these new techniques (2 pts with aggressive haemangiomas, 8 pts with myelomas and 23 pts with metastases) suffering from severe motion pain in the back, notwithstanding conservative treatment with medication and corset therapy, in the absence of neurological signs. In 3 selected patients we associated radiofrequency heat ablation with vertebroplasty in the treatment of metastases. The aim is to destroy tumor tissue and to thrombose the paravertebral and intravertebral venous plexus before stabilizing the vertebra.

Entities:  

Mesh:

Year:  2004        PMID: 15675473     DOI: 10.1080/1120009x.2004.11782379

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  11 in total

1.  Percutaneous vertebroplasty in vertebral compression fractures of benign or malignant origin: a prospective study of 1188 patients with follow-up of 12 months.

Authors:  Anastasios Mpotsaris; Razmin Abdolvahabi; Bastian Hoffleith; Janpeter Nickel; Ali Harati; Christian Loehr; Chun Hee Gerdes; Svenja Hennigs; Werner Weber
Journal:  Dtsch Arztebl Int       Date:  2011-05-13       Impact factor: 5.594

2.  Effect of augmentation techniques on the failure of pedicle screws under cranio-caudal cyclic loading.

Authors:  Richard Bostelmann; Alexander Keiler; Hans Jakob Steiger; Armin Scholz; Jan Frederick Cornelius; Werner Schmoelz
Journal:  Eur Spine J       Date:  2015-03-27       Impact factor: 3.134

3.  Percutaneous vertebroplasty: the radiologist's point of view.

Authors:  Salvatore Masala; Matteo Mammucari; Francesco Paolo Maria Fucci; Francesco Massari; Giovanni Simonetti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

4.  Percutaneous vertebroplasty in the management of vertebral osteoporotic fractures. Short-term, mid-term and long-term follow-up of 285 patients.

Authors:  Salvatore Masala; Matteo Mammucari; Georgios Angelopoulos; Roberto Fiori; Francesco Massari; Skerdilajd Faria; Giovanni Simonetti
Journal:  Skeletal Radiol       Date:  2009-05-12       Impact factor: 2.199

Review 5.  Kyphoplasty in osteoporotic vertebral compression fractures--guidelines and technical considerations.

Authors:  Yohan Robinson; Christoph E Heyde; Peter Försth; Claes Olerud
Journal:  J Orthop Surg Res       Date:  2011-08-19       Impact factor: 2.359

6.  Use of O-arm with neuronavigation in percutaneous vertebroplasty reduces the surgeon's exposure to intraoperative radiation.

Authors:  Maciej Wojdyn; Olaf Pierzak; Krzysztof Zapałowicz; Maciej Radek
Journal:  Arch Med Sci       Date:  2019-04-08       Impact factor: 3.318

7.  Augmentation of failed human vertebrae with critical un-contained lytic defect restores their structural competence under functional loading: An experimental study.

Authors:  Ron N Alkalay; Dietrich von Stechow; David B Hackney
Journal:  Clin Biomech (Bristol, Avon)       Date:  2015-03-28       Impact factor: 2.034

8.  Complications and safety aspects of kyphoplasty for osteoporotic vertebral fractures: a prospective follow-up study in 102 consecutive patients.

Authors:  Yohan Robinson; Sven Kevin Tschöke; Philip F Stahel; Ralph Kayser; Christoph E Heyde
Journal:  Patient Saf Surg       Date:  2008-01-15

9.  Balloon kyphoplasty in the treatment of metastatic disease of the spine: a 2-year prospective evaluation.

Authors:  R Pflugmacher; R Taylor; A Agarwal; I Melcher; A Disch; N P Haas; C Klostermann
Journal:  Eur Spine J       Date:  2008-06-17       Impact factor: 3.134

10.  Fracture care using percutaneously applied titanium mesh cages (OsseoFix®) for unstable osteoporotic thoracolumbar burst fractures is able to reduce cement-associated complications--results after 12 months.

Authors:  Stephan Albrecht Ender; Anica Eschler; Michaela Ender; Harry Rudolf Merk; Ralph Kayser
Journal:  J Orthop Surg Res       Date:  2015-11-14       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.